HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 3, Pages 354
Publisher
MDPI AG
Online
2020-07-03
DOI
10.3390/vaccines8030354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review
- (2020) Rita Medeiros et al. Acta Medica Portuguesa
- Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society
- (2020) Alexandru Barboi et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- World Health Organization call for action to eliminate cervical cancer globally
- (2020) Murat Gultekin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience
- (2020) Petrillo et al. Vaccines
- Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis
- (2020) Helena C Bartels et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women
- (2020) Katie Lichter et al. OBSTETRICS AND GYNECOLOGY
- Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women
- (2020) Mario Preti et al. Infectious Agents and Cancer
- Alpha, Beta, gamma human PapillomaViruses (HPV) detection with a different sets of primers in oropharyngeal swabs, anal and cervical samples
- (2019) Catia Sias et al. Virology Journal
- Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016
- (2019) Xavier Martínez-Gómez et al. Eurosurveillance
- Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions
- (2019) L. S. Velentzis et al. CLIMACTERIC
- Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population
- (2019) Anna R. Giuliano et al. GYNECOLOGIC ONCOLOGY
- Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy
- (2019) Elmar A. Joura et al. EUROPEAN JOURNAL OF CANCER
- Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status
- (2019) Freja L. Sand et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials
- (2019) Hilary S. Whitworth et al. VACCINE
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
- (2019) Marc Arbyn et al. Lancet Global Health
- Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis
- (2018) Chunqing Lin et al. LANCET INFECTIOUS DISEASES
- Human Papillomavirus Prophylactic Vaccination improves reproductive outcome in infertile patients with HPV semen infection: a retrospective study
- (2018) Andrea Garolla et al. Scientific Reports
- Background paper for the recommendation of HPV vaccination for boys in Germany
- (2018) Anja Takla et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- SPERANZA project: HPV vaccination after treatment for CIN2+
- (2018) Alessandro Ghelardi et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
- (2018) M. Arbyn et al. Expert Review of Vaccines
- Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy
- (2018) Mette Tuxen Faber et al. VACCINE
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- (2017) Warner K Huh et al. LANCET
- Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes
- (2017) Nikolai M. Scheller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis
- (2017) Maddalena D'Addario et al. VACCINE
- Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age
- (2017) Tino F. Schwarz et al. Cancer Medicine
- Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
- (2016) Allan Hildesheim et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Spontaneous fertility and in vitro fertilization outcome: new evidence of human papillomavirus sperm infection
- (2016) Andrea Garolla et al. FERTILITY AND STERILITY
- Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy:Post-hocanalysis from a randomized controlled trial
- (2016) Suzanne M. Garland et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women
- (2016) Ole-Erik Iversen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interventions to Improve HPV Vaccine Uptake: A Systematic Review
- (2016) E. B. Walling et al. PEDIATRICS
- Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines
- (2016) Pierre Van Damme et al. VACCINE
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
- (2015) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine
- (2015) Suzanne M. Garland et al. VACCINE
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial
- (2015) Ting Fan Leung et al. Human Vaccines & Immunotherapeutics
- Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage
- (2015) Linda M. Niccolai et al. JAMA Pediatrics
- Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
- (2014) S Rachel Skinner et al. LANCET
- Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women
- (2014) Joaquin Luna et al. PLoS One
- High HPV Infection Prevalence in Men from Infertile Couples and Lack of Relationship between Seminal HPV Infection and Sperm Quality
- (2014) Barbara Golob et al. Biomed Research International
- Detection of oncogenic human papillomavirus genotypes on spermatozoa from male partners of infertile couples
- (2013) Rosaria Schillaci et al. FERTILITY AND STERILITY
- Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?
- (2013) Woo Dae Kang et al. GYNECOLOGIC ONCOLOGY
- Safety of HPV vaccination: A FIGO statement
- (2013) International Federation of Gynecol INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HPV vaccination programme in Japan
- (2013) Stuart Gilmour et al. LANCET
- Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
- (2011) Barbara Romanowski et al. Human vaccines & immunotherapeutics
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Papilloma Virus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy
- (2010) Luciano Mariani et al. BMC CANCER
- Position paper—HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians
- (2010) José Ramet et al. EUROPEAN JOURNAL OF PEDIATRICS
- Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes
- (2010) Antonio Perino et al. FERTILITY AND STERILITY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started